Tegison
What is Tegison?
Etretinate (trade name Tegison) is a medication developed by Hoffmann–La Roche that was approved by the FDA in 1986 to treat severe psoriasis. It is a second-generation retinoid. It was subsequently removed from the Canadian market in 1996 and the United States market in 1998 due to the high risk of birth defects. It remains on the market in Japan.
Questions and answers on "Tegison"
Health resources related to Tegison
Recent questions on Tegison
Explore "Tegison"
Related Disease & Conditions
Related Procedures